Nature of tumour rejection antigens in ovarian cancer

Immunology
Muzamil Y WantKunle Odunsi

Abstract

Major progress in the analysis of human immune responses to cancer has been made through the molecular characterization of human tumour antigens. The development of therapeutic strategies for eliciting immune-mediated rejection of tumours has accelerated due to the elucidation of the molecular basis for tumour cell recognition and destruction by immune cells. Of the various human tumour antigens defined to date in ovarian cancer, the cancer-testis (CT) family of antigens have been studied extensively preclinically and clinically because of their testis-restricted expression in normal tissues and ability to elicit robust immune responses. Recent developments in cancer sequencing technologies offer a unique opportunity to identify tumour mutations with the highest likelihood of being expressed and recognized by the immune system. Such mutations, or neoantigens, could potentially serve as specific immune targets for T-cell-mediated destruction of cancer cells. This review will highlight current work in selecting tumour rejection antigens in ovarian cancer for improving the efficacy of immunotherapy.

References

Jun 1, 1991·Research in Immunology·C J Melief, W M Kast
Jan 1, 1995·Gynecologic and Obstetric Investigation·Y F WongT K Chung
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Nov 24, 1999·Immunological Reviews·R F Wang, S A Rosenberg
Dec 22, 1999·Immunogenetics·H RammenseeS Stevanović
Feb 5, 2000·Human Immunology·I AlgarraF Garrido
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Apr 30, 2003·Protein Science : a Publication of the Protein Society·Morten NielsenOle Lund
Jun 24, 2003·Immunity·Gabriel L SicaLieping Chen
May 1, 2004·Cancer Chemotherapy and Pharmacology·Argun AkcakanatKatsuyoshi Hatakeyama
Aug 17, 2004·Cancer Immunology, Immunotherapy : CII·Luisa NovellinoGiorgio Parmiani
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Jul 1, 2005·Protein Science : a Publication of the Protein Society·Pierre Dönnes, Oliver Kohlbacher
Jul 22, 2005·Nature Reviews. Cancer·Andrew J G SimpsonLloyd J Old
Aug 6, 2005·Applied Immunohistochemistry & Molecular Morphology : AIMM·Raffit HassanMark C Willingham
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Feb 1, 2006·Expert Review of Anticancer Therapy·Eugene T H Ek, Peter F M Choong
Apr 12, 2006·The Journal of Experimental Medicine·Ilona KryczekWeiping Zou
Oct 17, 2006·Current Oncology Reports·Thomas J Herzog
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael H KershawPatrick Hwu
Jul 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kunle OdunsiSacha Gnjatic
Feb 2, 2008·International Journal of Cancer. Journal International Du Cancer·Atsushi NatsumeJun Yoshida
Mar 21, 2008·Nature Reviews. Cancer·Steven A RosenbergMark E Dudley
Nov 13, 2008·Immunogenetics·Ilka HoofMorten Nielsen
Nov 18, 2008·The Lancet Oncology·Ajay P SinghSurinder K Batra
Feb 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Carmine CarpenitoCarl H June
Mar 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sacha GnjaticDirk Jäger
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Junko MatsuzakiKunle Odunsi
Jul 16, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alena A ChekmasovaRenier J Brentjens
Dec 16, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maria R ParkhurstSteven A Rosenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.